Skip to content


You currently have no items in your basket.

Total (excl. vat) £0.000
View basket & checkout


Founded in 1982 to provide researchers with tools that were not readily available from other commercial sources, SouthernBiotech has remained a steadfast, high-quality source of secondary antibodies. Over the years we have expanded our product line to meet researchers’ changing needs. What has not changed is our commitment to customer success.

By producing secondary antibodies, then primary antibodies, and additional immunoreagents that have been proven through numerous publications over the years, providing rapid and extensive customer support, and offering fully customizable services to ensure your needs are met, we demonstrate how serious we are about your success.

Small enough to be nimble and responsive, large enough to fulfill expansive manufacturing needs, SouthernBiotech is steadfastly at your side, ensuring your success.

View All SouthernBiotech Products

SouthernBiotech has steadily expanded its product portfolio over time. The company was initially renowned for its secondary antibodies, and since then, SouthernBiotech has broadened its offerings to include primary antibodies and a diverse array of immunoreagents. Through the provision of fully customisable services, the company ensures it meets the unique requirements of each research endeavour.

This tailored approach, combined with the company's accessibility and responsiveness, solidifies SouthernBiotech as a dependable partner for researchers across varying scales. Researchers can utilise SouthernBiotech's products and services, including monoclonal and polyclonal antibodies, secondary antibodies, and isotype controls, for a wide range of critical applications.

These include protein detection and quantification in Western blotting, ELISA, and immunohistochemistry assays, as well as flow cytometry and immunoprecipitation. Additionally, their IHC kits facilitate tissue and cell staining for visualising specific proteins, while collagen products are valuable for studying cell-matrix interactions and applications in tissue engineering.

SouthernBiotech offers a highly adaptable custom polyclonal antibody production service, catering to your specific requirements. For antibody generation, they can work on both small and large scales, following standard protocols or client-provided immunisation schedules. Additionally, SouthernBiotech also provides comprehensive antibody testing and characterisation, this includes serum titre evaluation, ELISA testing, endotoxin analysis, and various analytical techniques like HPLC, Western blot, flow cytometry, and immunohistochemistry.

The efficacy of these products is highlighted by their integration into numerous publications, demonstrating their pivotal role in advancing research. Take a look at some publications that use a range of SouthernBiotech products below.

Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 - Klingler, J., Weiss, S., Itri, V., Liu, X., Oguntuyo, K.Y., Stevens, C., Ikegame, S., Hung, C.T., Enyindah-Asonye, G., Amanat, F. and Baine, I., 2021. Role of immunoglobulin M and A antibodies in the neutralization of severe acute respiratory syndrome coronavirus 2. The Journal of infectious diseases.

Different doses of tannin reflect a double-edged impact on broiler chicken immunity - Ramah, A., Yasuda, M., Ohashi, Y., Urakawa, M., Kida, T., Yanagita, T., Uemura, R., Bakry, H.H., Abdelaleem, N.M. and El-Shewy, E.A., 2020. Different doses of tannin reflect a double-edged impact on broiler chicken immunity. Veterinary immunology and immunopathology.

Novel ACE2-IgG1 fusions with improved activity against SARS-CoV2 - Iwanaga, N., Cooper, L., Rong, L., Beddingfield, B., Crabtree, J., Tripp, R.A. and Kolls, J.K., 2020. Novel ACE2-IgG1 fusions with improved activity against SARS-CoV2.

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice - Spencer, A.J., McKay, P.F., Belij-Rammerstorfer, S., Ulaszewska, M., Bissett, C.D., Hu, K., Samnuan, K., Blakney, A.K., Wright, D., Sharpe, H.R. and Gilbride, C., 2021. Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice. Nature communications.

Our Mission

We are serious about ensuring our customers’ success because when our customers win the world wins. Enabling new treatments, better diagnostics, and the research that drives it all.

Our Vision

We are working towards a world where scientists can move seamlessly from idea to implementation because the reagents they need are available immediately.

Our Commitment

We are committed to providing the most reliable secondary and primary antibodies for customer success in diagnostic, drug development, and discovery study research.

Anti-Llama Secondary Antibodies

Secondary antibodies that are second to none

Anti-Llama Secondary Antibodies